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Purpose: Amblyopia is the most common cause of visual impairment in children. Early detection of amblyopia and
subsequent intervention are vital in preventing visual loss. Understanding the molecular pathogenesis of amblyopia would
greatly facilitate development of therapeutic interventions. An animal model of amblyopia induced by monocular vision
deprivation has been extensively studied in terms of anatomic and physiologic alterations that affect visual pathways.
However, the molecular events underlying these changes are poorly understood. This study aimed to characterize changes
of gene expression profiles in the lateral geniculate nucleus (LGN) associated with amblyopia induced by monocular
visual deprivation.
Methods: Monocular vision deprivation was generated by either opaque dark contact lens or tarsorrhaphy of newborn
rhesus monkeys. LGN was harvested at two or four months following induction of vision deprivation. Laser capture
microdissection was used to obtain individual LGN layers for total RNA isolation. Linear T7-based in vitro RNA
amplification was used to obtain sufficient RNA to conduct DNA microarray studies. The resulting Affymetrix GeneChip
Expression data were analyzed using Affymetrix GeneChip Operating Software. Real-time quantitative polymerase chain
reaction and in situ hybridization were used to further analyze expression of selected genes.
Results: Using 52,699 microarray probe sets from a Rhesus array, we identified 116 transcripts differentially expressed
between deprived and nondeprived parvocellular layers: 45 genes were downregulated and 71 genes were upregulated in
deprived parvocellular layers. We also observed substantial changes in deprived magnocellular laminae: 74 transcripts
exhibited altered expression, 42 genes were downregulated, and 32 genes were upregulated. The genes identified in this
study are involved in many diverse processes, including binding (calcium ion binding, nucleic acid binding, and nucleotide
binding), catalytic activity, and signal transducer activity.
Conclusions:  There  were  significant  differences  in  gene  expression  profiles  between  deprived  and  nondeprived
parvocellular layers and magnocellular laminae of LGN. These alterations in gene expression may play a critical role in
the molecular pathogenesis of amblyopia. The genes identified in this study may provide potential targets for therapeutic
intervention of this disease.
Amblyopia is the most common and significant disorder
of  spatial  vision  in  children.  It  is  characterized  by  a
constellation  of  progressive  visual  deficits,  including
deficiencies  in  spatial  vision,  contrast  sensitivity,  grating
acuity, and flicker sensitivity. These vision deficits, in turn,
severely impair eye alignment and eye movement control. The
severity of amblyopia depends on the magnitude, age of onset,
and  duration  of  visual  deprivation.  It  can  produce  severe
acuity loss, even leading to functional blindness in an eye, if
not appropriately identified and treated.
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To  prevent  amblyopia,  adequate  visual  sensory
experiences  must  be  maintained  throughout  postnatal
development. The postnatal window, when the visual system
is developing, is referred to as the critical period. During this
critical period, adequate visual sensory experience must be
maintained to allow for the proper development of the visual
system, especially in the lateral geniculate nucleus (LGN) and
primary visual cortex (V1). Aberrant visual experience (e.g.,
unilateral  cataract)  during  the  critical  period  produces
irreversible functional alterations in LGN and V1, ultimately
leading to amblyopia.
Our  current  understanding  of  the  etiology  and
pathogenesis  of  amblyopia  comes  largely  from  clinical
observations and electrophysiological studies in children and
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1401from  anatomic/physiologic  studies  in  nonhuman  primate
models.  Although  these  studies  have  added  to  our
understanding of amblyopia, little is known about what causes
amblyopia at the molecular level. Important questions yet to
be answered include the following: Are gene and protein
expression patterns altered at different levels of visuomotor
relay and processing pathways? What cellular-level signaling
pathways are responsible for the physiologic changes that
produce  amblyopia?  This  study  attempts  to  address  these
relevant questions.
We  hypothesized  that  the  anatomic  and  physiologic
changes associated with amblyopia are regulated by genes and
proteins, and characterization of changes in gene expression
profiling  would  allow  identification  of  important  genes
involved  in  the  molecular  pathogenesis  of  amblyopia.  To
address this hypothesis, we used rhesus macaque monkeys as
our model system to study gene expression profiles for the
following reasons: First, humans and rhesus monkeys have
similar  visual-oculomotor  behavior  and  primary  visual
pathways. Other animals such as rodents, rabbits, cats, and
even New World primates do not have the ability to perform
volitional smooth-pursuit. Second, the visual systems and the
structure of LGN of humans and rhesus monkeys are similar
in terms of organization and susceptibility to early problems
in visual experience. Third, rhesus monkeys have already
been accepted and used as an animal model for studying visual
cortical  function  and  performance.  Therefore,  rhesus
monkeys  provide  unique  advantages  for  gene  expression
profiling studies of amblyopia.
Monkeys with monocular vision deprivation are one of
the most accepted and validated models for amblyopia [1,2].
The  monkey  visual  system  exhibits  two  distinct  critical
periods: birth to eight weeks and eight weeks to one year [3].
During the first critical period, monocular vision deprivation
initially  produces  transient  hypertrophy  of  neurons  in  the
nondeprived parvocellular laminae. During the second critical
period,  the  size  of  the  neurons  of  the  nondeprived
parvocellular  laminae  is  restored  and  the  neurons  of  the
deprived parvocellular laminae undergo atrophy [4-7]. The
atrophic phase is much less pronounced in the magnocellular
layers of both anisometropic and strabismic amblyopes [8,9].
Both magnocellular and parvocellular pathway are affected
by monocular vision deprivation or amblyopia. Recent studies
suggest  that  koniocellular  (K)  LGN  cells  (intercalated
between  the  laminae)  make  up  the  koniocellular  pathway
[10-13]. Recent studies also suggest that LGN neuron size
alterations are a consequence of interactions between V1 and
LGN, but little is known about the cellular and molecular
events behind these changes [3,14,15].
In the LGN of the monocular vision-deprived monkey,
three  layers  are  deprived  and  three  other  layers  are
nondeprived. Taking the whole LGN for study of the gene
expression profile would not allow us to compare and contrast
gene  expression  in  deprived  and  nondeprived  layers.
Therefore, we used laser capture microdissection (LCM) to
obtain  individual  deprived  or  nondeprived  layers.  These
layers were then coupled with the Rhesus Macaque Genome
Array to compare gene expression patterns between deprived
and nondeprived layers of monocular vision-deprived LGN.
We identified several genes with altered expression patterns,
which  might  play  an  important  role  in  the  molecular
pathogenesis of amblyopia.
METHODS
Animals and tissue preparation: Seven monkeys were used in
our study. Infant monkeys were born in captivity at Yerkes
National Primate Research Center (YNPRC), Atlanta, GA.
The infants were hand raised in a dedicated infant monkey
nursery facility at YNPRC. Infants were fed standard infant
formula and diet on an approved feeding schedule according
to age and size. No food or water restrictions were used in
association with any of our testing. Two normal control rhesus
monkeys  (Macaca  mulatta),  designated  C1  and  C2,  were
reared under a normal 12 h:12 h light-dark cycle for four
months. Two rhesus monkeys, designated MD1 and MD2,
were monocular vision-deprived by placing an opaque, dark
contact lens, in each animal’s left eye. The uniocular contact
lens rearing began at birth and extended for two months. The
extended wear, gas permeable lens was replaced on a daily
basis with a like sterilized opaque contact lens. Three rhesus
monkeys, designated MD3, MD4, and MD5, were vision-
deprived in the left eye at birth by tarsorrhaphy and were
observed  for  four  months.  Testing  visual  function  of  the
deprived eye occurred at 4 months of age after the eyelid of
the deprived eye was opened. All monocular vision-deprived
monkeys were reared under the same conditions as normal
control monkeys. Following deep sedation with Telazol (4
mg/kg, I.M.), monkeys were sacrificed by delivering a bolus
of Nembutol (90 mg/kg, I.V.). Both left and right LGN were
dissected  out,  immediately  embedded  in  optimal  cutting
temperature  (OCT)  compound  (Sakura  Finetek,  Torrance,
CA), snap frozen in liquid nitrogen, and kept at −80 °C before
cryostat sectioning. The LGNs of monkeys MD1 and MD3
were used for LCM and microarray gene expression studies.
All  animal  procedures  were  approved  by  the  Institutional
Animal Care and Use Committee at Emory University and
Case Western Reserve University.
Acuity testing in infant monkeys: We used a two-alternative,
forced-choice, preferential looking (FPL) method to assess the
visual  acuity  of  our  monkeys  during  monocular  viewing
conditions. Visual acuity of each eye was assessed during the
first two months or four months by precisely calibrated Teller
Acuity Cards using the general procedures outlined in the
acuity card manual (Vistech Consultants, Inc., 1990, Dayton,
OH). Each card had black and white stripes of a particular
spatial frequency on one side, surrounded by an isoluminant
gray background. Briefly, two experimenters referred to as the
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1402“observer”  and  the  “holder,”  participated  in  testing  each
monkey. The holder positioned the infant monkey in front of
a gray screen that has an open window at its center. The
observer sat on the other side of the screen and placed a test
card in the window where the monkey could view it. For
monocular vision testing, a small circular patch or contact lens
occluder was placed over the fellow eye. This procedure was
repeated using cards with various spatial frequencies until the
highest spatial frequency that the monkey could locate was
determined. We carefully monitored the disposition of the
infant during this procedure to be certain that it was relaxed
and attentive.
Infant monkeys naturally prefer looking at a patterned
stimulus (grating) compared to a uniform gray level field.
When these stimuli were presented, the infant looked toward
the grating, provided its spatial frequency was not too high.
The infant’s looking behavior fell to chance performance as
the spatial frequency of the grating was increased. Therefore,
FPL  provides  a  well  established  clinical  tool  for  use  in
noncooperative  subjects  (e.g.,  infant  monkeys)  to  assess
normal  and  abnormal  acuity  development  [16].  Our
monocular vision-deprived monkeys were able to reliably
look at gratings of up to 19 cycles/degree using the eye that
had unaltered vision during the rearing period. In contrast, no
reliable preferential looking was observed when testing the
deprived eyes of our animals, even for low spatial frequency
stimuli (<1.0 cycles/degree). These findings were consistent
with profound amblyopia of the deprived eye.
Laser capture microdissection: OCT-embedded LGN tissue
was sectioned at 10 μm using a cryostat and placed on Leica
membrane slides (PET-Membrane, Wetzlar, Germany). The
slides were immediately transferred to a −80 °C freezer, LGNs
of MD1 and MD3 monocular vision-deprived monkeys were
used for the LCM and microarray study. Rapid toluidine blue
staining was used to identify different layers. Briefly, the
sections  were  fixed  in  75%  ethanol  for  30  s,  and  then
immersed in 0.05% toluidine blue in 20% ethanol for 30 s,
followed by dehydration and wash with graded alcohols (75%,
95%, and 100%) for 20 s each. Four parvocellular layers and
two magnocellular layers from each LGN were subjected to
laser  capture  microdissection.  Six  layers  represented
nondeprived layers (layers I, IV, and VI of ipsilateral, layers
II, III, and V of contralateral deprived eye) and six layers of
LGN represented monocular vision-deprived layers (layers II,
III, and V of ipsilateral, layers I, IV, and VI of contralateral).
The Leica Biosystems AS LCM was used for laser capture
microdissection. Each parvocellular and magnocellular layers
were microdissected by LCM to exclude the koniocellular
layer,  as  shown  by  Figure  1.  These  different  layers  were
Figure  1.  Morphology  of  LGN
parvocellular layers from a monkey with
monocular vision deprivation. A: H&E
staining  of  lateral  geniculate  nucleus
(LGN)  sections  showed  neuronal
shrinkage  in  deprived  parvocellular
layers as compared with non-deprived
layers.  B:  Low  power  magnification
deprived layer of LGN sections before
laser  capture  microdissection  (LCM).
C: Low power magnification deprived
layer  of  LGN  sections  after  LCM.
Abbreviations: dep: deprived layer; ND:
non-deprived layer.
Molecular Vision 2008; 14:1401-1413 <http://www.molvis.org/molvis/v14/a169> © 2008 Molecular Vision
1403placed into the RNA sample buffer [17] immediately after
dissection.
RNA  isolation,  linear  amplification  and  hybridization  for
microarray: We pooled LCM samples from 6–10 sections of
each individual layer from each LGN. Total RNA from each
layer was isolated using the PicoPure RNA isolation kit with
DNase  I  digestion  (Arcturus,  Mountain  View,  CA).  The
quality of isolated RNA from LCM samples was measured by
NanoDrop, Wilmington, DE. A260/A280 ratios were between
1.9 and 2.2 for all LCM samples. Two rounds of linear T7-
based RNA amplification were then performed. The protocol
of RNA amplification was generously provided by Dr. Eric
Hoffman  (Children's  National  Medical  Center,  George
Washington  University,  Washington,  DC).  Similar
techniques have previously been conducted in our laboratory
[17] and others [18-20]. RNA amplification allowed for the
production  of  microgram  quantities  of  antisense  RNA
(aRNA)  without  distorting  gene-to-gene  ratios  to  obtain
sufficient RNA for DNA microarray studies, as previously
described [17,21,22]. Briefly, we used 100–250 ng of total
RNA as starting material and applied two rounds of RNA
amplification in which first-strand synthesis yielded cDNA
incorporating  a  T7  promoter  primer,  and  second-strand
synthesis yielded double-stranded cDNA (cDNA synthesis kit
Figure  2.  Transcripts  that  were  downregulated  in  deprived
parvocellular layers as compared with non-deprived layers of 2 or 4
months  after  monocular  vision  deprivation.  A:  Hierarchical
dendogran analysis displayed genes downregulated (blue to green
color) in deprived layers as compared with non-deprived layers. B:
Pie  chart  displayed  functional  categorization  of  genes  that  were
downregulated in deprived layers. Number in parentheses indicated
how many genes involved in that category function. P3-P6 represent
parvocellular layer III to VI. Abbreviations: Dep: deprived layer;
Non-Dep: non-deprived layer; 2 months or 4 months: 2 or 4 months
of monocular vision deprivation.
from  Invitrogen,  Carlsbad,  CA).  Following  cDNA
purification,  in  vitro  transcription  (IVT)  using  T7  RNA
polymerase yielded antisense RNA (cRNA; MEGAscript kit;
Ambion, Austin, TX). Then, cRNA was used in the second
round of amplification for first-strand cDNA synthesis with
random primers and second-strand cDNA synthesis with T7
promoter primer. This yielded double-stranded cDNA, which
was used in a second IVT reaction to generate biotinylated
cRNA  using  T7  RNA  polymerase  and  biotin-labeled
nucleotides  (Affymetrix,  Santa  Clara,  CA).  Biotin-labeled
cRNA was used for hybridization according to the directions
in the Affymetrix GeneChip Expression Analysis Manual.
Briefly, after purification and fragmentation, 15 μg cRNA was
added in a 300 μl hybridization mixture containing spiked IVT
controls. Approximately 200 μl of this mixture was hybridized
to DNA microarrays chip for 16 h at 45 °C in an Affymetrix
GeneChip  Fluidics  Station  400.  A  Hewlett-Packard  Gene
Array Scanner was used for microarray scanning.
Microarray data analysis: Affymetrix GeneChip Operating
Software  (GCOS)  version  1.4  was  used  for  initial  data
processing  and  fold  ratio  analysis.  The  GCOS  algorithm
analyzes data by 1) assessing probe pairs for perfect match
and mismatch to determine the presence or absence calls of
individual genes; 2) normalizing raw values to calculate their
Figure 3. Transcripts that were upregulated in deprived parvocellular
layers as compared with non-deprived layers of 2 or 4 months after
monocular vision deprivation. A: Hierarchical dendogran analysis
displayed genes upregulated (orange to red color) in deprived layers
as  compared  with  non-deprived  layers.  B:  Pie  chart  displayed
functional categorization of genes that were upregulated in deprived
layers. Number in parentheses indicated how many genes involved
in that category function. P3-P6 represent parvocellular layer III to
VI. Abbreviations: Dep: deprived layer; Non-Dep: non-deprived
layer.2 months or 4 months: 2 or 4 months of monocular vision
deprivation.
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1404relative  expression  levels;  and  3)  employing  statistical
techniques to make increase, decrease, or no change calls. Any
transcripts with expression intensities below 100 across all the
samples  were  excluded  since  distortion  of  the  n-fold
difference values results when expression levels are low and
may be within the level of background noise (background
noise averaged 54 for 24 samples). Transcripts that had an
absent call in all the samples were also eliminated from further
analysis.
Pairwise comparisons were used between deprived layers
and  nondeprived  layers  of  parvocellular  or  magnocellular
laminae in the same LGN of the monocular vision-deprived
monkey.  For  comparisons  of  deprived  and  nondeprived
parvocellular  layers,  transcripts  defined  as  differentially
regulated met the following criteria: six out of eight increase/
decrease calls in deprived layers versus nondeprived layers in
eight replicates from the parvocellular layers; and absolute
value of the average fold difference value ≥ 1.7. For deprived
and  nondeprived  magnocellular  layers,  transcripts  were
defined as differentially regulated if they met the following
criteria:  four  out  of  four  increase/decrease  calls  in  four
replicates; and absolute value of the average fold difference
value ≥ 1.7.
Figure  4.  Transcripts  that  were  downregulated  in  deprived
magnocellular layers as compared with non-deprived layers of 2 or
4  months  after  monocular  vision  deprivation.  A:  Hierarchical
dendogran analysis displayed genes downregulated (blue to green
color) in deprived layers as compared with non-deprived layers. B:
Pie  chart  displayed  functional  categorization  of  genes  that  were
downregulated in deprived layers. Number in parentheses indicated
how  many  genes  involved  in  that  category  function.  M1-M2
represent magnocellular layer I to II. Abbreviations: Dep: deprived
layer; Non-Dep: non-deprived layer; 2 months or 4 months: 2 or 4
months of monocular vision deprivation.
The quality of the microarray results were evaluated by
comparing  results  of  genes  that  were  represented  in  the
Affymetrix chip more than once [23,24]. To determine the
function of genes, we used GeneSpring software GX 7.3.1
(Agilent Technologies, Foster City, CA) and methodology of
GeneSpring  in  conjunction  with  resources  provided  by
Weizmann Institute of Science GeneCards online databases
and  the  National  Center  for  Biotechnology  Information
(NCBI) Entrez.
Real-time quantitative polymerase chain reaction technique:
Selected transcripts were verified by qRT–PCR in triplicate.
Briefly, transcript-specific primers were generated based on
human sequences from GeneBank and were designed using
Primer Express software (Applied Biosystems, Inc., Foster
City, CA). NCBI BLAST was used to ensure specificity of
each primer pair for each transcript. Reverse transcription and
qRT–PCR  was  performed  with  an  ABI  7000  sequence
detection  instrument.  Monkey  glyceraldehyde  phosphate
dehydrogenase (GAPDH) was used as an internal control to
normalize the qRT–PCR data. Mean fold changes between the
two study groups were calculated by averaging the triplicate
measurements  for  each  gene.  The  relative  fold  difference
calculation used the 2-∆∆CT method [25].
Figure  5.  Transcripts  that  were  upregulated  in  deprived
magnocellular layers as compared with non-deprived layers of 2 or
4  months  after  monocular  vision  deprivation.  A:  Hierarchical
dendogran analysis displayed genes upregulated (orange to red color)
in deprived layers as compared with non-deprived layers. B: Pie chart
displayed functional categorization of genes that were upregulated
in deprived layers. Number in parentheses indicated how many genes
involved in that category function. M1-M2 represent magnocellular
layer I to II. Abbreviations: Dep: deprived layer; Non-Dep: non-
deprived layer. 2 months or 4 months: 2 or 4 months of monocular
vision deprivation.
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1405In situ hybridization: The PCR primers were designed based
on  human  gene  sequences  derived  from  GenBank.  PCR
reactions  were  performed  using  monkey  LGN  for
corticotrophin-releasing  hormone  (CRH)  and  gamma-
aminobutyric acid A receptor, alpha 1 (GABRA1).
The PCR products were subcloned into a pCR II vector
using the TA Cloning Kit (Invitrogen), and each sequence was
confirmed  by  sequencing  (CRH  monkey  in  situ  probe
sequence has 97% homologies with its human sequence, and
GABRA1  monkey  in  situ  probe  sequence  has  98%
homologies with its human sequence). Digoxigenin (DIG)-
labeled cRNA probes were made using the DIG RNA labeling
kit (SP6/T7) and the protocol provided by Roche. The labeled
probes were precipitated with ethanol, and then washed to
remove  unincorporated  digoxigenin-labeled  nucleotides.
Tissue blocks containing the LGN were sectioned at 10 µm
on  a  cryostat.  Nonradioactively  labeled  probe  in  situ
hybridization procedures were performed using the method
described by us previously [17,26]. Briefly, the slides were
dried for 2 h, fixed in 4% paraformaldehyde/PBS for 30 min
at  room  temperature,  washed  with  PBS,  treated  with
Proteinase K at 1 µg/µl for 15 min at room temperature,
acetylated  for  10  min  and  then  prehybridization  was
performed at room temperature for 2 h. The DIG-cRNA probe
was heated at 80 °C for 5 min and chilled on ice. Hybridization
was performed at 65 °C overnight in a humidified chamber in
hybridization buffer that consisted of 50% formamide, 5X
SSC, 5X Denhardts, 250 µg/ml baker’s yeast RNA, and 500
µg/ml salmon sperm DNA. The slides were washed with 0.2X
SSC at 65 °C for 3 h. They were then blocked with 10% heat-
inactivated  sheep  serum  for  1  h  followed  by  incubation
overnight  in  an  anti-DIG  antibody  (anti-DIG-AP;  Fab
fragment, Roche, Nutley, NJ) that was diluted 1:5000 in buffer
consisting of 100 mM Tris pH 7.5, 0.15 M NaCl. Visualization
of  the  signal  was  detected  with  4-nitro  blue  tetrazolium
chloride/5-bromo-4-chloro-3-indolyl-phosphate  (NBT/
BCIP), and the alkaline phosphatase reaction was stopped by
washing with Tris EDTA buffer (10 mM Tris pH 7.5, 1 mM
EDTA). The slides were then dehydrated and mounted with
permanent mounting medium.
In situ hybridization quantification: Images were collected
with an RT Slider digital camera (Diagnostic Instruments,
Sterling  Heights,  MI)  mounted  on  an  Olympus  BX  60
Microscope  using  a  2X  objective.  Resulting  12  bit
Figure 6. In situ hybridization of CRH
in  control  and  LGN.  A  and  B:  CRH
expression in the LGN of two control
monkeys  (C1and  C2).  C:  Ipsilateral
LGN of a monkey that was monocular
vision-deprived for four months (MD5).
D: CRH showed decreased expression
in deprived layers (layers I, IV, and VI)
in the LGN contralateral to the eye from
a monkey that was monocular vision-
deprived  for  four  months  (MD3).  E.
Higher-magnification photomicrograph
of D. F: Ipsilateral LGN from a monkey
that was monocular vision-deprived for
two (MD2). G. CRH showed decreased
expression in deprived layers (layers II,
III, and V) in the LGN ipsilateral to the
eye from a monkey that was monocular
vision-deprived for four months (MD4).
H:  Higher-magnification
photomicrograph of G. I: Contralateral
LGN  eye  from  a  monkey  that  was
monocular  vision-deprived  for  four
months (MD4).
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1406monochrome  images  were  analyzed  using  Metamorph
software  (Universal  Imaging,  Downington,  PA).  Briefly,
individual regions were drawn to differentiate the six layers
of monkey LGN. Within each region the amount of positive
in  situ  signal  was  selected  by  thresholding.  The  percent
thresholded represents the percentage area of positive in situ
signal contained in a given region. All images were collected,
calibrated and analyzed using identical parameters. Image
Figure  8.  Quantification  for  in  situ  hybridization  of  CRH  and
GABRA1 in deprived LGN. Percent threshold area represents the
percentage of area in a given layer that contains a positive in situ
hybridization signal. The purple colored graph bar is Dep M which
indicates deprived magnocellular layers. The red colored graph bar
is non-dep M which indicates nondeprived magnocellular layers. The
light blue colored graph bar is Dep P which indicates deprived
parvocellular layers. The green colored graph bar is non-dep P which
indicates nondeprived parvocellular layers. The asterisk Denotes a
p<0.05 for deprived layers compared to nondeprived layers.
data were then exported to Excel for further analysis and
signal quantification.
RESULTS
Generating amblyopic monkey model: The deprived monkeys
showed visual acuity in the viewing eye similar to that of
normal age-matched control monkeys. In contrast, the vision-
deprived eye, tested at two months of age for two monkeys
and  four  months  of  age  for  three  monkeys  with  the  FPL
method, had no measurable acuity even when the grating
stimuli were less than 1 cycle/degree.
Altered  gene  expression  in  lateral  geniculate  nucleus-
deprived laminae of monocular vision-deprived monkey: All
24 samples (12 samples were from LGNs of monkeys that
were  monocular  vision-deprived  for  two  months  and  12
samples were from LGNs of monkeys that were monocular
vision-deprived  for  four  months)  were  hybridized  to  the
Rhesus Macaque Genome Array. The percentage of genes on
the  microarray  reported  as  present  in  24  samples  ranged
43.7%–52.4%. The microarray data were deposited in the
NCBI GEO web-based data repository (series ID: GSE9795).
Also, 12 samples from LGNs of monkey deprived for four
months were hybridized to the HG-U133Aplus2 array, and the
microarray data were deposited in the NCBI GEO web-based
data repository (series ID: GSE2165).
LCM and microarray technology were used to identify
genes that were differentially expressed between deprived and
nondeprived  parvocellular  layers  of  monocular  vision-
deprived monkeys. Our data showed that, of the 52,699 probe
sets, 116 transcripts were differentially expressed between
deprived and nondeprived parvocellular layers; 45 genes were
downregulated  and  71  transcripts  were  upregulated  in
Figure  7.  In  situ  hybridization  of
GABRA1 in control and deprived LGN.
A and B: GABRA1 expression in the
LGN of two control monkeys (C1 and
C2).  C:  GABRA1  showed  decreased
expression in deprived layers (layers II,
III, and V) in the LGN ipsilateral to the
eye from a monkey that was monocular
vision-deprived for four months (MD4).
D:  GABRA1  showed  decreased
expression in deprived layers (layers I,
IV, and VI) in the LGN contralateral to
the  eye  from  a  monkey  that  was
monocular  vision-deprived  for  four
months  (MD3).  E:  Higher-
magnification photomicrograph of D. F:
Higher-magnification photomicrograph
of C.
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1407deprived layers. The expression levels of 45 downregulated
genes were displayed in a hierarchical dendogram generated
by the GeneSpring software (Figure 2A), and transcripts were
classified  according  to  their  functions  (Figure  2B).  The
functions were further classified into molecular functions,
biologic  processes,  and  cellular  components,  which  were
subclassified according to their activity. Most downregulated
genes in the molecular functions were involved in binding
(44.4%), in catalytic activity (17.8%), and in signal transducer
activity (15.6%). A further analysis of these binding genes
revealed that calcium ion binding, nucleic acid binding, and
nucleotide binding genes were abundant in this category. The
majority  of  downregulated  genes  in  the  biologic  process
included  genes  involved  in  cellular  process  (46.7%)  and
physiologic processes (37.8%). Cell-cell signaling and signal
transduction  genes  and  genes  related  to  metabolisms
represented the major part of the cellular process. The genes
downregulated  in  the  cellular  components  were  mainly
involved in cell (42.2%), extracellular region (17.8%), and
organelle  (11.1%).  Genes  downregulated  in  deprived
parvocellular layers were listed in Appendix 1.
The  71  upregulated  genes  were  also  displayed  in  a
hierarchical  dendogram  generated  by  the  GeneSpring
software (Figure 3A) and transcripts were classified according
to their functions (Figure 3B). In the molecular function, most
upregulated  genes  were  involved  in  binding  (28.2%),  in
catalytic activity (14.1%), and in signal transducer activity
(8.4%). A further analysis of these upregulated binding genes
revealed that calcium ion binding, nucleic acid binding, and
nucleotide binding genes accounted for most of the genes in
the binding function category. In the biologic process group,
the majority of upregulated genes were involved in cellular
process (35.2%), physiologic process (32.4%), development
(15.5%), and regulation of biologic process (12.7%). A further
analysis showed that cell communication and cell growth/
maintenance  genes  were  the  major  genes  involved  in  the
cellular process group. Of these, host-pathogen interaction
and signal transduction genes were the major part of the cell
communication group. The genes related to cell growth and
metabolisms  were  the  major  genes  in  the  cell  growth/
maintenance category. Cell (33.8%) and organelle (15.5%)
function genes were heavily represented in upregulated genes
in  the  cellular  component  group.  Genes  upregulated  in
deprived parvocellular layers were listed in Appendix 2.
There were also 74 transcripts that exhibited different
expression  levels  between  the  deprived  and  nondeprived
magnocellular layers: 42 genes were downregulated and 32
were  upregulated  in  deprived  magnocellular  layers.  The
expression levels of 42 downregulated genes were displayed
in a hierarchical dendogram generated by the GeneSpring
software  (Figure  4A),  and  transcripts  were  classified
according to their functions (Figure 4B). In the molecular
function  group,  most  of  the  downregulated  genes  were
involved in binding (38.1%), in catalytic activity (23.8%), and
in signal transducer activity (14.3%). A further analysis of
these downregulated binding genes revealed that calcium ion
binding and nucleic acid binding genes were the major part of
the binding function category. In the biologic processes group,
the majority of downregulated genes were involved in cellular
process (38.1%), physiologic process (31%), and regulation
of biologic process (14.3%). In the cellular process category,
cell-cell  signaling  and  signal  transduction  genes  were  the
major genes downregulated in the cell communication group,
and  metabolism  related  genes  were  the  major  genes
downregulated in the cell growth/maintenance group. Cell
(40.5%),  organelle  (11.9%),  and  protein  complex  (9.5%)
genes were heavily represented in the genes downregulated in
the  cellular  component  category.  Appendix  3  listed
downregulated genes in deprived magnocellular layers. The
upregulated genes were displayed in a hierarchical dendogram
generated  by  the  GeneSpring  software  (Figure  5A)  and
transcripts classified according to their functions (Figure 5B).
Binding (43.8%) genes was the major genes upregulated in
the molecular function category. A further analysis of these
upregulated binding genes revealed that nucleic acid binding
and nucleotide binding genes were the main genes involved
in binding function. In the biologic processes, the majority of
upregulated genes were involved in cellular process (37.5%),
physiologic process (28.1%), and development (15.6%). Cell-
cell  signaling,  host-pathology  interaction,  and  signal
transduction  genes  played  a  major  part  in  the  cell
communication  group,  and  metabolism  related  genes
accounted  for  the  cell  growth/maintenance  portion  in  the
cellular  process  category.  The  genes  upregulated  in  the
cellular  components  group  were  mainly  involved  in  cell
(40.6%), organelle (25%), and extracellular region groups
(18.8%).  Table  1  listed  upregulated  genes  in  deprived
magnocellular layers.
Verification  of  differential  gene  expression  by  quantative
reverse transcription polymerase chain reaction: We selected
several differentially expressed genes involved in cell-cell
signaling and signal transduction as detected by microarray
for verification by qRT–PCR. The qRT–PCR results were
consistent with the microarray data for all the genes verified.
For  example,  CRH  and  GABRA1  were  downregulated  in
deprived parvocellular layers by 2.3 fold and 1.7 fold by
microarray  and  4.3  fold  and  2.5  fold  by  qRT–PCR.
Dihydropyrimidinase-like 3 (DPYSL3) was upregulated in
deprived parvocellular layers by 2 fold by microarray and 2.5
fold by qRT–PCR. The primers used in qRT–PCR and fold
changes of genes were listed in Table 2.
Verification  of  differential  gene  expression  by  in  situ
hybridization:  Several  differentially  expressed  genes
involved in cell-cell signaling as detected by microarray were
analyzed by in situ hybridization. Primers generated for in situ
probes are listed in Table 2. Expression of CRH and GABRA1
was downregulated in deprived layers of deprived monkeys.
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1408The  microarray  results  were  confirmed  by  in  situ
hybridization. The density of staining was markedly reduced
in deprived layers II, III, and V (Figure 6C,F,G,H) and I, IV,
and VI (Figure 6D,E,I) for CRH (Figure 6). The density of
staining was markedly reduced in deprived layers II, III, and
V (Figure 7C,F) and I, IV, and VI (Figure 7D,E) for GABRA1
(Figure 7). The density of staining of CRH and GABRA1 was
quantified for LGN in deprived monkeys (Figure 8). In normal
control LGN, the density of staining for CRH and GABRA1
was  evenly  distributed  in  parvocellular  or  magnocellular
layers. These findings support the reliability of our microarray
results.
DISCUSSION
Understanding the molecular pathogenesis of amblyopia is a
necessary step toward the discovery of effective therapies.
Our present study demonstrates that we have established a
powerful model to study the molecular mechanisms related to
monocular  vision-deprivation-induced  amblyopia  in
nonhuman primates. By using laser capture microdissection
and  DNA  microarray  techniques  in  a  monocular  vision-
deprived  monkey,  we  have  obtained  a  snapshot  of  gene
expression in LGN at a time when anatomic and cellular
alterations  resulting  from  visual  deprivation  are  well
established.
Distinct  anatomic  and  cellular  alterations  have  been
shown to occur in the LGN of monkeys that have undergone
two or four months of visual deprivation. Our microarray
analysis revealed 190 genes with altered expression due to
visual  deprivation  in  the  parvocellular  and  magnocellular
layers of LGN. Although this is a relatively small number, the
genes identified are involved in many diverse processes and
are quite likely to play roles in the pathogenesis of amblyopia
associated with monocular vision deprivation.
The  primary  anatomic  changes  of  the  deprived  LGN
parvocellular  layer  include  neuronal  loss  and  atrophy.
Consistent  with  these  findings,  our  expression  profiling
discovered several differentially expressed genes that were
reported to be involved in controlling neuronal apoptosis and
atrophy, including CRH which might prove to be particularly
important in driving the anatomic changes associated with
monocular vision deprivation. Reduced CRH expression was
detected in the deprived layers of LGN in monkeys deprived
TABLE 1. TRANSCRIPTS THAT WERE UPREGULATED IN DEPRIVED MAGNOCELLULAR LAYERS AS COMPARED WITH NON-DEPRIVED LAYERS
Affymatrix ID RefSeq                Gene Symbol    Transcripts Fold Change
MmugDNA.2791.1.S1_at NM_002581 PAPPA pregnancy-associated plasma protein A, pappalysin 1 9.1
MmuSTS.1876.1.S1_at NM_080803 COL13A1 collagen, type XIII, alpha 1 8.3
MmuSTS.3434.1.S1_at NM_170696 ALDH1A2 aldehyde dehydrogenase 1 family, member A2 5.4
MmugDNA.7497.1.S1_at NM_213609 FAM19A1 family with sequence similarity 19, member A1 4.6
MmugDNA.27876.1.S1_at NM_002581 PAPPA pregnancy-associated plasma protein A, pappalysin 1 4.2
MmuSTS.3785.1.S1_at AY436323 AGT angiotensinogen (serine/cysteine) proteinase inhibitor 4.2
MmugDNA.18346.1.S1_at NM_198541 IGFL1 insulin growth factor-like family member 1 3.9
MmugDNA.22116.1.S1_at NM_006183 NTS neurotensin 3.8
MmugDNA.13685.1.S1_at     unknown 3.7
MmuSTS.3385.1.S1_at NM_181523 PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 3.7
MmugDNA.35490.1.S1_at NM_006328 RBM14 RNA binding motif protein 14 3.3
MmugDNA.14651.1.S1_at NM_004904 CREB5 cAMP responsive element binding protein 5 3.2
MmugDNA.37283.1.S1_at NM_021190 PTBP2 Polypyrimidine tract binding protein 2 3.1
MmugDNA.17471.1.S1_at NM_024749 FLJ12505 Hypothetical protein FLJ12505 3.0
MmugDNA.38329.1.S1_at NM_032160 C18orf4 chromosome 18 open reading frame 4 3.0
MmugDNA.37023.1.S1_at NM_006147 IRF6 interferon regulatory factor 6 2.8
MmugDNA.38004.1.S1_at     Transcribed locus 2.7
MmugDNA.29288.1.S1_at NM_015393   unknown 2.5
MmugDNA.37083.1.S1_at NM_145753 PHLDB2 pleckstrin homology-like domain, family B, member 2 2.5
MmugDNA.6639.1.S1_at     Transcribed locus 2.4
MmugDNA.22537.1.S1_s_at NM_002291 LAMB1 laminin, beta 1 2.2
MmuSTS.3615.1.S1_at NM_001266 CES1 carboxylesterase 1 2.1
MmugDNA.42270.1.S1_at NM_013372 GREM1 gremlin 1, cysteine knot superfamily 2.0
MmugDNA.9692.1.S1_at     unknown 2.0
MmugDNA.15114.1.S1_at NM_001812 CENPC1 centromere protein C 1 1.9
MmugDNA.32812.1.S1_at NM_006108 SPON1 spondin 1, extracellular matrix protein 1.9
MmugDNA.6252.1.S1_s_at NM_001670 ARVCF armadillo repeat gene deletes in velocardiofacial syndrome 1.9
MmuSTS.3940.1.S1_at NM_007269 STXBP3 syntaxin binding protein 3 1.9
MmugDNA.39862.1.S1_at NM_001280 CIRBP cold inducible RNA binding protein 1.8
MmugDNA.8458.1.S1_at NM_000527 LDLR low density lipoprotein receptor 1.8
MmugDNA.34471.1.S1_at NM_025154 UNC84A unc-84 homolog A (C. elegans) 1.7
MmugDNA.39414.1.S1_at NM_002130 HMGCS1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 1.7
Affymatrix ID is ID from Affymatrix GeneChip. RefSeq, Gene Symbol, and Transcripts are the gene ID, gene symbol and gene
name from GenBank. Number indicated fold change.
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1409for two or four months (cross-species hybridization using the
human chip showed the same result, which was deposited in
the GEO as GSE2165). Once thought to be only involved in
maintaining  neuroendocrine  responses  to  induce  cell-cell
signaling and signal transduction, the role of CRH has now
been  expanded  and  is  thought  to  be  involved  in  several
apoptotic pathways. In primary neuronal culture, CRH was
protective  against  cell  death  caused  by  an  amyloid-beta
peptide. This effect was blocked by a CRH receptor antagonist
and by an inhibitor of cyclic AMP-dependent protein kinase.
CRH can also protect neurons against cell death caused by
lipid  peroxidation  and  the  excitotoxic  neurotransmitter
glutamate [27]. Therefore, the reduction in CRH expression
levels observed in the present study suggests that CRH might
account  for  the  reduction  of  LGN  neuron  number  in  the
deprived layers. CRH stimulates cAMP production in various
regions of the central nervous system and binds specifically
to CRH receptor type 1 (which also was downregulated in our
study),  which  leads  to  stimulation  of  multiple  G-proteins
associated  with  several  putative  intracellular  signaling
pathways [28]. Downregulation of CRH expression has also
been observed in some neurodegenerative diseases such as
Alzheimer disease [29-31] and Huntington disease [32]. A
potential role for reduced CRH in neuron loss in the LGN of
deprived monkeys has not been previously considered, but
could be of particular importance.
GABA,  the  major  inhibitory  neurotransmitter  in  the
mammalian brain, functions through the GABA-A receptor
(GABRA). GABRA is a ligand gated chloride channel that
has been shown to be involved in visual cortical plasticity. The
TABLE 2. VERIFICATION OF THE DATA BY QRT-PCR
Gene Primer sequence
Microarray fold
change qRT-PCR fold change
NDST4 5’-CCCCAAAGCCAAGATCATCA-3’ -3.7 -3.3
  5’-ACCTCAGAGCAGCTGGATCTTC-3
CRH 5’-GCAGCAGCAACACAATGTTATTC-3’ -2.3 -4.3
  5’-ACGTTTTCTCACAGGTCTACATTCTC-3’
KCNC3 5’-CTTGTCACCGCCTGAGACCT-3’ -2.0 -2.7
  5’-GAGATTTGAAGCCCAGTGTCTT-3’
STAT4 5’-GGTTGTCTGCTCTGCCATTC-3’ -1.9 -2.4
  5’-TTTGGGAATGTCAGGATATAGG-3’
WNT5A 5’-TTGCAGCGTATCACTGTTATGA-3’ -1.8 -2.5
  5’-TTCAAGTACACTGGGAACAGTTTT-3’
GABRA1 5’-AAGAGGTCAAGCCCGAAACA-3’ -1.7 -2.5
  5’-AAATAGCAGCGGGAAGGCTAT-3’
NQO2 5’-CCACGAAGCCTACAAGCAAAG-3’ -1.7 -3.1
  5’-AGTACAGCGGGAACTGAAATATCAC-3’
CAMK2A 5’-ATCACTGGCCTCTGTCCTTG-3’ 1.8 2.3
  5’-ATGGGATCACTGGGCCTTACT-3’
CREB5 5’-GCTCACCACTCACAGAACAGAC-3’ 1.9 2.6
  5’-TTAAAAGAAAGGACGCATGGTA-3’
DPYSL3 5’-GCTGACACCTGAGCCTGGAT-3’ 2.0 2.5
  5’-GGAGAAAGCCTGGGAAGCTT-3’
PIK3R1 5’-TCATTGAACAGCAAAGTAGGATTCA-3’ 2.4 3.2
  5’-CGGTGGGCAAGCTACACTGTA-3’
SCN3B 5’-GACCATAGCTGCTTCCTTTTCT-3’ 2.4 3.7
  5’-AGAAGCAGTGAGTGGGATTAGG-3’
HRK 5’-GGAGCCCAGAGCTTGAAAGG-3’ 4.1 4.4
  5’-CCCCAGTCCCATTCTGTGTT-3’
ALDH1A2 5’-AGTGTCTTCTGCAATGCAAGC-3’ 5.4 6.3
  5’-CATTTCTCTCCCATTTCCAGAC-3’
CRH 5’-CTCACAGCAACAGGAAACTC-3’ -2.3 primers for in situ
  5'-CTCTTACACAACCAAACTGACCAA-3'
GABRA1 5’-TATTGCCGTGTGCTATGCCTTTGT-3’ -1.7 primers for in situ
  5’-AGATGGGAATTACTGCGTTGAGAA-3’
The PCR primers were designed based on human gene sequences derived from GenBank. Primers for in situ hybridization
probes were  generated  by  PCR  reactions  using  monkey  corticotrophin-releasing  hormone  (CRH ;  accession  number
NM_000756) and gamma-aminobutyric acid A receptor, alpha 1 (GABRA1 from accession number NM_000806).
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1410onset of critical period can be delayed by low levels of GABA
and accelerated by enhancing its inhibition [33]. One subunit
of this receptor is GABRA alpha 1 (GABRA1). Our study
showed a reduction of GABRA1 mRNA in deprived layers of
LGN  (cross-species  hybridization  using  the  human  chip
showed the same result, which was deposited in the GEO as
GSE2165). Our finding further supports the importance of
GABA  activity  in  the  pathology  of  monocular  vision
deprivation.  The  finding  is  also  consistent  with  previous
studies on monkeys [34,35], which showed reduced GABA
activity in the deprived LGN. Hendry and Miller [36] reported
decreased GABRA1 protein, and Huntsman and colleagues
[37] reported decreased mRNA in deprived LGN.
Prior  gene  expression  profiling  studies  to  compare
deprived and nondeprived layers of the LGN in monocular
vision-deprived monkey are scarce. This is the first paper to
study deprived and nondeprived layers of the LGN in the
monocular vision-deprived monkey at the molecular level by
using  LCM  and  Rhesus  chip  microarray.  Lachance  and
Chaudhuri [21] used similar techniques on the normal vervet
monkey (an Old World species) and samples cross-hybridized
to the Rhesus array. Prasad et al. [38,39] used monkey cDNA
array  to  study  gene  profiling  of  parvocellular  and
magnocellular layers, but did not dissect individual layers. In
the  present  study,  we  used  laser  capture  microdissection,
which allowed a more precise dissection of each layer. We
also used genome-wide expression profiling technology to
allow screening of more genes. Our microarray data proved
reliable  as  several  selected  differentially  expressed  genes
were verified by qRT–PCR and in situ hybridization.
In summary, by using laser capture microdissection and
DNA microarray techniques in a monocular vision-deprived
amblyopia monkey model, we found significant differences
in  the  gene  expression  profile  between  deprived  and
nondeprived parvocellular layers and magnocellular laminae.
We identified genes that were upregulated or downregulated
in LGN associated with visual deprivation. These alterations
in gene expression may play a critical role in the molecular
pathogenesis of amblyopia. The genes identified in this study
are involved in many diverse processes, including cell-cell
signaling/binding  (calcium  ion  binding,  nucleic  acid  and
nucleotide  binding),  catalytic  activity/metabolisms,  and
signal  transducer  activity.  Change  of  expression  levels  of
these genes may indeed drive the anatomic and physiologic
alterations from visual deprivation. The findings may provide
insights  into  understanding  molecular  pathogenesis  of
amblyopia.  It  is  also  possible  that  some  anatomic  and
physiologic  alterations  seen  in  visual  deprivation  may  be
caused by post-transcriptional regulation of genes. Further
identification  of  molecular  pathophysiologic  pathways  of
monocular vision deprivation and gene expression changes in
the visual cortex will increase our understanding of disease
causing mechanisms. These may eventually lead to effective
therapeutic interventions to slow or reverse the consequences
of monocular vision deprivation during visual development,
such as amblyopia from congenital cataract. We focused on
the genes with similar expression changes after two and four
months  of  monocular  vision  deprivation.  However,  it  is
possible that changes of genes at one time point related to
amblyopia and may or may not related to maturation might be
missed by the current selection of differentially expressed
genes.  However,  all  of  our  monkeys  displayed  profound
amblyopia at both two months and four months time points,
indicating that a steady-state of amblyopia has been reached
at these two time points. The model applied here would be
also useful in designing future studies to unravel the molecular
alterations in other parts of the visual pathways including the
primary visual cortex.
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Appendix  1.  Transcripts  that  were  downregulated  in  deprived
parvocellular layers as compared with non-deprived layers.
To access the data, click or select the words “Appendix
1”. This will initiate the download of a (pdf) archive that
contains  the  file.  Affymatrix  ID  is  ID  from  Affymatrix
GeneChip. RefSeq, Gene Symbol, and Transcripts are the
gene ID, gene symbol and gene name from GenBank. Number
indicated fold change, negative indicated downregulated. A
positive  fold  change  means  the  corresponding  gene  was
upregulated in deprived layers.
Appendix 2. Transcripts that were upregulated in deprived parvocellular
layers as compared with non-deprived layers.
To access the data, click or select the words “Appendix
2”. This will initiate the download of a (pdf) archive that
contains  the  file.  Affymatrix  ID  is  ID  from  Affymatrix
GeneChip. RefSeq, Gene Symbol, and Transcripts are the
gene ID, gene symbol and gene name from GenBank. Number
indicated fold change.
Appendix  3.  Transcripts  that  were  downregulated  in  deprived
magnocellular layers as compared with non-deprived layers
To access the data, click or select the words “Appendix
3”. This will initiate the download of a (pdf) archive that
contains  the  file.  Affymatrix  ID  is  ID  from  Affymatrix
GeneChip. RefSeq, Gene Symbol, and Transcripts are the
gene ID, gene symbol and gene name from GenBank. Number
indicated fold change, negative indicated downregulated.
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